The authors characterized the progression of liver degeneration in LS-G6pc−/− mice and demonstrated that these mice exhibit hepatic symptoms similar to those of human GSD-1a, including hepatomegaly, steatosis and glycogen accumulation. Here, G6PC1 is linked to steatosis.